Best Cannabis Stocks Under $10
Updated March 2026Cannabis stocks trading below $10 per share, ranked by market cap. Mid-priced marijuana stocks with growth potential.
Cannabis stocks under $10 represent a broad cross-section of the marijuana industry, ranging from large-cap multi-state operators to emerging biotech companies and international cultivators. This price range captures many of the sector's most actively traded names and offers a balance between affordability and business quality that appeals to both retail and institutional investors.
Unlike sub-$1 or sub-$5 stocks, companies trading between $5 and $10 are more likely to meet major exchange listing requirements and attract analyst coverage. Several well-known MSOs, licensed producers, and ancillary companies fall into this bracket — businesses with hundreds of millions in annual revenue, positive gross margins, and expanding state or international footprints.
The ranking below organizes sub-$10 cannabis stocks by market capitalization, giving you a quick view of which companies in this price tier command the greatest overall market value. Use this as a starting point for deeper research into individual company financials, growth trajectories, and competitive positioning.
Best Cannabis Stocks Under $10 — Full Rankings
30 stocks · Ranked by market cap
| # | Ticker | Name | Price | Change | Market Cap | Revenue | Margin | P/S | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CURLF | Curaleaf Holdings | $2.36 | +2.83% | $1.80B | $0 | — | — | $1.80B |
| 2 | GTBIF | Green Thumb Industries | $6.56 | +7.01% | $1.54B | $0 | — | — | $1.54B |
| 3 | TCNNF | Trulieve Cannabis | $6.40 | +4.92% | $1.22B | $0 | — | — | $1.22B |
| 4 | CRON | Cronos Group | $2.50 | +0.81% | $947.6M | $146.6M | 36.4% | 6.46x | $947.6M |
| 5 | TLRY | Tilray Brands | $6.89 | -1.57% | $802.7M | $837.3M | 26.4% | 0.96x | $802.7M |
| 6 | MSOS | AdvisorShares Pure US Cannabis ETF | $3.82 | +1.33% | $764.3M | $0 | — | — | $764.3M |
| 7 | GLASF | Glass House Brands | $7.50 | -2.72% | $608.3M | $0 | — | — | $608.3M |
| 8 | VRNOF | Verano Holdings | $1.26 | -8.70% | $457.6M | $0 | — | — | $457.6M |
| 9 | SNDL | SNDL Inc | $1.51 | -5.03% | $388.8M | $0 | — | — | $388.8M |
| 10 | CGC | Canopy Growth | $1.02 | -2.86% | $385.4M | $278.4M | 28.8% | 1.38x | $385.4M |
| 11 | KERN | Akerna Corp | $6.27 | +24.64% | $376.3M | $6.8M | 402.0% | 55.05x | $376.3M |
| 12 | INNPF | InnocanPharma | $5.07 | 0.00% | $354.9M | $0 | — | — | $354.9M |
| 13 | CRLBF | Cresco Labs | $0.97 | -0.27% | $346.1M | $0 | — | — | $346.1M |
| 14 | VFF | Village Farms International | $2.87 | -6.51% | $331.5M | $253.3M | 38.7% | 1.31x | $331.5M |
| 15 | PLNHF | Planet 13 Holdings | $0.91 | +5.21% | $295.8M | $0 | — | — | $295.8M |
| 16 | TSNDF | TerrAscend Corp | $0.68 | +0.37% | $261.4M | $0 | — | — | $261.4M |
| 17 | CCHWF | Columbia Care | $1.14 | -4.20% | $232.6M | $0 | — | — | $232.6M |
| 18 | HITI | High Tide Inc | $2.46 | +2.50% | $216.1M | $0 | — | — | $216.1M |
| 19 | ACB | Aurora Cannabis | $3.43 | -3.65% | $194.5M | $0 | — | — | $194.5M |
| 20 | OGI | Organigram Holdings | $1.41 | -2.76% | $190.6M | $0 | — | — | $190.6M |
| 21 | GDNSF | Vireo Growth (Goodness Growth) | $0.44 | -1.12% | $182.2M | $0 | — | — | $182.2M |
| 22 | CBWTF | Auxly Cannabis Group | $0.09 | +1.07% | $111.6M | $0 | — | — | $111.6M |
| 23 | CWBHF | Charlotte's Web Holdings | $0.62 | -0.22% | $99.3M | $0 | — | — | $99.3M |
| 24 | JUSHF | Jushi Holdings | $0.49 | -0.26% | $96.4M | $0 | — | — | $96.4M |
| 25 | LOVFF | Cannara Biotech | $1.30 | -5.09% | $81.9M | $0 | — | — | $81.9M |
| 26 | MAPS | WM Technology (Weedmaps) | $0.68 | -7.27% | $73.0M | $174.7M | 94.9% | 0.42x | $73.0M |
| 27 | HEXO | HEXO Corp | $0.71 | +5.62% | $68.9M | $0 | — | — | $68.9M |
| 28 | FORA | Forian Inc | $2.05 | -0.97% | $63.7M | $28.1M | 51.6% | 2.27x | $63.7M |
| 29 | GRWG | GrowGeneration | $1.06 | -2.75% | $63.4M | $161.4M | 27.2% | 0.39x | $63.4M |
| 30 | AFCG | AFC Gamma (Advanced Flower Capital) | $2.63 | +0.38% | $61.9M | $24.6M | — | 2.52x | $61.9M |
Top 3 Spotlight
Curaleaf Holdings
Curaleaf Holdings ranks #1 in the best cannabis stocks under $10 category with a share price of $2.36 and a market capitalization of $1.80B. The company operates in the MSO sector and is listed on the OTC. With trailing twelve-month revenue of $0 and a gross margin of N/A, CURLF represents the top-ranked stock in this category based on market cap.
Green Thumb Industries
Green Thumb Industries ranks #2 in the best cannabis stocks under $10 category with a share price of $6.56 and a market capitalization of $1.54B. The company operates in the MSO sector and is listed on the OTC. With trailing twelve-month revenue of $0 and a gross margin of N/A, GTBIF represents the second-ranked stock in this category based on market cap.
Trulieve Cannabis
Trulieve Cannabis ranks #3 in the best cannabis stocks under $10 category with a share price of $6.40 and a market capitalization of $1.22B. The company operates in the MSO sector and is listed on the OTC. With trailing twelve-month revenue of $0 and a gross margin of N/A, TCNNF represents the third-ranked stock in this category based on market cap.
Methodology
Stocks are filtered to include only cannabis companies with a share price below $10.00 and ranked in descending order by market capitalization. Data is sourced from company filings, exchange feeds, and financial data providers. Rankings update automatically as new data becomes available. All financial figures are based on trailing twelve-month (TTM) data unless otherwise noted. The current ranking includes 30 qualifying stocks out of 100 total cannabis companies tracked by Cannabismarketcap.
Key Observations
The top-ranked stock in the best cannabis stocks under $10 category is CURLF (Curaleaf Holdings) with a market cap of $1.80B. The stock trades at $2.36 per share with a market capitalization of $1.80B. In second place is GTBIF ($1.54B), followed by TCNNF ($1.22B) in third.
Across all 30 qualifying stocks, the average share price is $2.50 and the average market capitalization is $420.4M. The combined trailing twelve-month revenue of all companies in this category is $1.91B. The average gross margin among companies with positive margins is 88.3%. The average price-to-sales ratio is 7.86x.
The most represented sector in this category is MSO with 11 out of 30 companies (37%). Among the ranked stocks, 12 are trading higher today while 17 are trading lower. Investors should use these observations as a starting point for further research rather than as the basis for trading decisions.
Investment Considerations
When evaluating stocks in the best cannabis stocks under $10 category, consider looking beyond the primary ranking metric to build a holistic view of each company. A stock that ranks well by market cap may have weaknesses in other areas — such as high debt, poor margins, or slowing growth — that the ranking alone does not capture. Cross-reference this list with other Cannabismarketcap category pages and the screener tool to identify stocks that score well across multiple dimensions.
Position sizing is particularly important in cannabis. The sector is inherently volatile, and even the strongest companies can experience 30-50% drawdowns during sector-wide sell-offs triggered by legislative disappointments or broader market risk-off events. Most financial advisors suggest limiting total cannabis exposure to 5-15% of your portfolio, and individual positions to 1-3% depending on your risk tolerance and conviction level.
Dollar-cost averaging (DCA) is a widely recommended approach for building cannabis stock positions over time. Rather than investing your entire allocation at a single price point, spreading purchases across weeks or months can reduce the impact of short-term volatility and lower your average cost basis if prices decline after your initial purchase. This strategy is particularly relevant for the stocks in this category given the sector's history of sharp and sometimes prolonged drawdowns.
Risk Factors
Risk Warning
While less speculative than sub-$1 stocks, cannabis companies under $10 still face sector-wide headwinds including federal prohibition, 280E taxation, limited banking access, and regulatory uncertainty at the state level. Many companies in this range are not yet profitable on a GAAP basis and continue to burn cash. Share prices in this tier can be highly volatile around earnings releases, legislative developments, and broader market risk-off events. Investors should assess each company's balance sheet strength, path to profitability, and exposure to regulatory changes before investing.
Compare These Stocks
Head-to-head comparisons between top-ranked stocks in this category.
Frequently Asked Questions
What types of cannabis companies trade under $10?
The sub-$10 tier includes a diverse mix of company types. You'll find large-cap MSOs with billion-dollar enterprise values whose per-share prices are low due to high share counts, mid-cap licensed producers from Canada, ancillary companies that provide technology, equipment, or services to the cannabis industry, REITs that own cultivation and retail properties, and biotech firms developing cannabinoid-based pharmaceuticals. This variety means you can build a diversified cannabis portfolio entirely within this price range.
Are cannabis stocks under $10 suitable for long-term investing?
Some are and some are not. Companies with consistent revenue growth, improving margins, and a clear path to profitability can be strong long-term holdings regardless of current share price. However, companies that are declining in revenue, increasing debt, and diluting shareholders are likely to continue losing value. Focus on the business fundamentals rather than the share price itself — a $9 stock with deteriorating metrics is a worse long-term investment than a $3 stock with accelerating growth.
How do cannabis stocks under $10 compare to cannabis ETFs?
Individual stocks under $10 offer more targeted exposure and higher upside potential than ETFs, but with correspondingly higher risk. Cannabis ETFs like MSOS or MJ provide instant diversification across the sector but charge expense ratios (typically 0.70-0.80%) and may hold positions in companies you would not choose individually. If you have strong conviction in specific companies, buying individual stocks gives you more control. If you want broad sector exposure with less research effort, an ETF may be more appropriate.
What is the best strategy for buying cannabis stocks under $10?
Dollar-cost averaging (DCA) is often recommended for cannabis stocks due to their high volatility. Rather than investing your entire allocation at once, spread purchases over weeks or months to smooth out price fluctuations. Additionally, consider limiting cannabis to 5-15% of your total portfolio given the sector's risk profile. Within that allocation, diversify across sub-sectors (MSOs, LPs, ancillary) and geographies (US, Canada) to reduce company-specific risk.
More on Cannabismarketcap
Disclaimer: The information on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Cannabis stocks are highly speculative and carry significant risk of loss, including the potential loss of your entire investment. Past performance is not indicative of future results. The rankings and data presented are based on publicly available financial information and may contain errors or omissions. Always do your own research and consult with a qualified financial advisor before making investment decisions. Cannabismarketcap is not a registered investment advisor, broker-dealer, or financial planner.